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Abstract
The various types of redox partner interactions employed in cytochrome P450 systems are described. The similarities and
differences between the redox components in the major categories of P450 systems present in bacteria, mitochondria and
microsomes are discussed in the light of the accumulated evidence from X-ray crystallographic and NMR spectroscopic
determinations. Molecular modeling of the interactions between the redox components in various P450 mono-oxygenase
systems is proposed on the basis of structural and mutagenesis information, together with experimental findings based on
chemical modification of key residues likely to be associated with complementary binding sites on certain typical P450
isoforms and their respective redox partners. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: Cytochrome P450; Redox partner interaction; Electron transfer rate
1. Introduction
Enzymes of the cytochrome P450 (CYP) superfam-
ily of heme-thiolate proteins are found in most bio-
logical species from all ¢ve kingdoms (monera, pro-
toctista, fungi, plantae and animalia) where they are
associated primarily with the oxidative metabolism
of a vast number of endogenous and exogenous com-
pounds [1]. It would appear that the CYP gene
superfamily evolved from a common ancestor over
a period of some 3.5 billion years (reviewed in [2])
thus explaining the fact that CYP proteins are fairly
ubiquitous in the biosphere. Although it is likely that
these isozymes contain common structural character-
istics in keeping with their functionality as mono-
oxygenases, it is apparent that di¡erences exist in
their electron transport chains when one compares
CYP systems from eukaryotic and prokaryotic or-
ganisms [3,4]. Nevertheless, the usual mono-oxygen-
ase reaction, mediated by P450, can be represented as
follows:
RHO2ÿ!2e
3
2H
ROHH2O
where a hydrocarbon substrate, RH, combines with
molecular dioxygen to form a hydroxylated metabo-
lite, ROH, and a molecule of water. The reaction
cycle requires the sequential input of two reducing
equivalents (i.e., two electrons and two protons)
which essentially activate the relatively inert oxygen
molecule (due to its triplet ground state) to the for-
mal level of peroxide (reviewed in [5]).
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The reducing equivalents for the P450-catalyzed
reaction are supplied by either NADPH or NADH,
depending on the type of redox system concerned,
and electron transfer is mediated by two co-factors,
one of which is FAD; the other being either FMN or
an iron^sulfur Fe2S2 redoxin or, in the microsomal
system, cytochrome b5 [6]. Table 1 summarizes the
various types of redox partners operating in most
P450 systems. In particular, the majority of bacterial
P450s utilize an electron transport chain which con-
sists of an FAD-containing NADH-dependent oxi-
doreductase, and reduction is mediated by an iron^
sulfur (Fe2S2) redoxin. The mitochondrial system in
mammalia bears many similarities with the prokary-
otic P450 electron transport chain, except that
NADPH is the source of reducing equivalents, and
both systems are generally referred to as Class I [3].
In fact, the similarity between mitochondrial and
bacterial P450 redox partners had led to the sugges-
tion that there may be an evolutionary linkage be-
tween certain types of bacterial cells, such as the
pseudomonads, and eukaryotic mitochondria (re-
viewed in [2]). At least one type of prokaryotic
P450 system di¡ers from the Class I category; this
is the unusual isoform P450BMÿ3 (CYP102) from Ba-
cillus megaterium which comprises a covalently
linked oxidoreductase, thus contributing to the enzy-
me’s high catalytic turnover [11,12]. As the oxidore-
ductase moiety of CYP102 consists of both FAD and
FMN domains for mediating electron transfer from
NADPH, in common with the microsomal P450-de-
pendent chain, the hemoprotein component of this
system is assigned to Class II P450s [3]. However,
in contrast with the CYP102 system, microsomal
P450s do not possess a covalently-linked oxidoreduc-
tase and this fact may partially explain the relatively
slow rate of substrate turnover in the latter. Another
factor is likely to be the competition between P450s
for reductase, even within an oligomeric complex,
and recent calculation for typical protein oligomers
[13] show a satisfactory agreement with experimental
dissociation constants, although it was assumed that
hydrogen bonding was the major contributor to pro-
tein-protein interactions. The general view of the
P450-reductase binding, however, assumes an essen-
tially electrostatic association.
Microsomal P450s in mammalian liver also utilize
cytochrome b5 as a second source of electrons, where
the reductant is NADH and electron transfer is
mediated by cytochrome b5 reductase which is an
FAD-containing oxidoreductase [14]. Accumulated
experimental evidence points to the involvement of
cytochrome b5 primarily for the second reduction
step in the hepatic microsomal P450 system [15^17].
Furthermore, it has been demonstrated that cyto-
chrome b5 is also able to bind avidly with the
bacterial P450s, CYP101 [18^20] and CYP102 [21],
although it does not appear to be able to act as
a reductant in the CYP101 system, possibly due
to its relatively high redox potential (+25 mV)
compared with that of substrate-bound CYP101
(3173 mV).
Table 1
Types of redox system in P450 monooxygenases
Classa Type Electron transport chain
I Bacterialb NADHCFAD-containing reductaseCiron^sulfur redoxinCP450
Mitochondrial NADPHCFAD-containing reductaseCiron^sulfur redoxinCP450
II Microsomalc NADPHCFAD- and FMN-containing reductaseCP450
Bacillus megaterium (BM3)d NADPHCFAD- and FMN-containing reductaseCP450
aClass III P450s include allene oxide synthase (CYP74), thromboxane synthase (CYP5A1) and prostacyclin synthase (CYP8). These
do not require an auxillary redox partner and do not catalyze monooxygenase reactions. These unusual forms of P450 are involved in
the rearrangement of endoperoxides or hydroperoxides [7].
bMost bacterial P450s possess this form of electron transfer chain, with the notable exception of CYP102 which is an example of
Class II P450 monoxygenase.
cThe microsomal system in mammalia also involves the mediation of cytochrome b5 (associated with cytochrome b5 reductase for elec-
tron transfer from NADH) primarily for the second reduction step in the catalytic cycle.
dThe redox system in Bacillus megaterium (CYP102) comprises directly-linked reductase and hemoprotein domains within a single
polypeptide chain. In this respect, the BM-3 system represents a counterpart to nitric oxide synthase (NOS), although it is clear from
the recent crystal structure [8] that NOS is not a P450-like hemoprotein [9,10].
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2. Redox status of the P450 system
2.1. Redox potentials of the components
Table 2 provides a summary of the redox poten-
tials for di¡erent components and redox species
present in both the bacterial P450cam (CYP101) and
the hepatic microsomal P450LM2 (CYP2B4) system.
It can be appreciated from an inspection of Table 2
that the various components in the P450 redox sys-
tems form a potential gradient whereby electrons can
£ow from reductant to oxidant in the series:
NADH! FAD! redoxin! P450bacterial system
or
NADPH! FAD! FMN
! P450microsomal system
where the arrow denotes the direction of single elec-
tron £ow [3,6]. It can also be seen, from the data
presented in Table 2, that substrate binding to
P450 alters the heme iron redox potential such that
reduction from its immediate redox partner in ener-
getically favorable. For example, putidaredoxin has a
redox potential of 3240 mV, which only permits
supply of electrons to P450cam (CYP101) with cam-
phor substrate bound, as this raises the redox poten-
tial (i.e., becomes less negative) from 3303 mV to
3173 mV (Table 2). Similar circumstances are appar-
ent in the microsomal system, although Guengerich
and Johnson [28] have shown that reduction of sub-
strate-free P450 enzymes is also possible [28] and
CYP102 behaves similarly [29].
Ultimately, the reduced P450 is required to reduce
molecular dioxygen in two sequential stages to,
¢rstly, superoxide and then to the level of peroxide,
which could constitute either the active oxygenating
species itself or its precursor (reviewed in [5,30]). The
oxygen redox couples presented in Table 2 are con-
sistent with energetically favorable reduction by
P450, although the second reduction step could in-
volve electron transfer to an alternative iron-coordi-
nated oxygen species, possibly Fe3Oo, for which the
redox potential may be signi¢cantly di¡erent (re-
viewed in [5]).
2.2. Rates of electron transfer in P450 systems
As the P450 catalytic cycle requires the input of
two reducing equivalents (two protons and two elec-
trons) which are delivered consecutively, the overall
rate of reaction is dependent on the ability of the
P450 redox components to transfer electrons. In par-
ticular, the catalytic turnover of both Class I and II
P450 systems is largely determined by the rate of the
second reduction step. Table 3 shows the relevant
data for a typical microsomal Class II P450. From
this table, it can be appreciated that rates of electron
transfer in the bacterial system are generally higher
than for the microsomal system. Furthermore, it is
apparent that cytochrome b5 is able to act as an
Table 2
Redox potentials of species involved in the P450 catalytic cycle
Microsomal system Bacterial system
Species Eo
0
(mV) Species Eo
0
(mV)
NADPH 3324 NADH 3320
FAD 3290 FAD 3290
FMN 3270 Putidaredoxin 3240
P450LM2 3300 (3substrate) P450cam 3303 (3substrate)
P450LM2 3225 (+substrate) P450cam 3173 (+substrate)
O2/O3c2 3160 O2/O
3c
2 3160
O3c2 /O2H
c 3100 O3c2 /O2H
c 3100
P450LM2 is now given the nomenclature CYP2B4, whereas P450cam is now referred to as CYP101 [1] according to the new system.
Substrate binding generally lowers the redox potential of P450 by about 100 mV, thus facilitating electron transfer from reductant
(NADPH or NADH) along a descending potential gradient mediated by either FAD and FMN (microsomal system) or FAD and an
iron^sulfur redoxin (bacterial or mitochondrial system). In the hepatic microsomal system, reduction can also be cytochrome b5-depen-
dent, which tends to occur primarily for the second reducing equivalent. The redox potential of cytochrome b5 is about 25 mV. and,
for this pathway, electron transfer from NADH is mediated by cytochrome b5 reductase. References: [22^27].
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alternative redox component for electron transfer in
the hepatic microsomal P450 system, where it exhib-
its an enhanced rate of transfer of the second elec-
tron relative to oxidoreductase [15]. Cytochrome b5
can also bind to CYP101 with high a⁄nity, as shown
in Table 3, although its relatively high redox poten-
tial (Eo = +25 mV) is incompatible with a possible
role as a reductant of P450cam (CYP101) as men-
tioned previously, and the rate of electron transfer
is relatively slow compared with putidaredoxin. In
fact, cytochrome b5 can be itself reduced by this
P450 isoform [14].
It can be demonstrated that the extent of NADPH
oxidation by microsomal P450s is related to the re-
dox potential observed in the absence of substrate
[35], where increased rates of NADPH turnover are
generally associated with an increase in the P450 he-
moprotein Eo values (i.e., the Fe2/Fe3 redox po-
tential becomes less negative). This and other ¢nd-
ings for substrate-bound P450s are consistent with
the theory that an increased electron transfer free
energy change (vG) is proportional to the magnitude
of the di¡erence in redox potentials between the two
interacting species, when expressed as an electro-
chemical cell of electromotive force (emf), Ecell, as
follows:
vG  3nFEcell
where n is the number of electrons involved in the
cell reaction and F is the Faraday constant
(9.6485U104 Coulombs/mol). Moreover, it is gener-
ally found that substrate binding elevates the P450
redox potential, thus facilitating reduction by the re-
dox partner, although exceptions do exist, as has
been reported by Guengerich and Johnson [28].
Nevertheless, the accumulated evidence from several
studies indicates that the initial binding of substrate
triggers the entire P450 catalytic cycle by enabling
the ¢rst reduction of the hemoprotein to proceed
via redox potential elevation (i.e., becomes less neg-
ative) which, incidentally, occurs when the P450 is
primarily in the high-spin state. Indeed, there ap-
pears to be a coupling between hemoprotein redox
and spin-state equilibria which has been observed in
both bacterial [36] and microsomal systems [22].
An associated aspect of the Fe2/Fe3 redox po-
tentials in hemoproteins generally concerns the rela-
tionship with the proportion of heme exposed to the
environment. Stellwagen [37] has reported that there
is an inverse correlation (r = 0.96) between heme iron
redox potential (Eo
0
) and percentage heme exposure
for seven diverse hemoproteins (namely: cyto-
chromes b5 and c, hemoglobin and myoglobin) as
follows:
Eo
0  343:88314:94% 1:95 heme exposure
The relevant data associated with this expression
are summarized in Table 4. In these examples, how-
ever, all of the hemoproteins exhibit positive redox
potentials and, consequently, it is not clear whether
this relation could also apply to the P450 system
since the data refer to globins and other types of
cytochromes with calculations carried out on the
crystal structures of each hemoprotein [37] prior to
those of any P450 being determined. Although the
three globins and cytochrome b5 listed in Table 4
possess histidine ligands to the heme iron, the three
cytochromes c structures all have methionine as
proximal heme ligands. There is, therefore, some de-
gree of similarity in the latter with P450s as these
Table 3
Electron transfer rate constants and dissociation constants for redox partners
Redox partner CYP Pseudo ¢rst-order rate constant (kapp) Dissociation constant (Kd)
Putidaredoxin 101 30^33 s31 (1st and 2nd e3) 5.4 WM (17 WM also reported)
Cytochrome b5 101 3^4 s31 (2nd e3)a 0.6 WM (0.65 WM also reported)
Cytochrome b5 2B4 2^7 s31 (2nd e3) 0.02 WM (0.4 WM also reported)
Reductase 2B4/1 11.5^18 s31 (1st e3) ; 1.1 s31 (2nd e3) 0.07 WM (0.1 WM reported for 2B1)
It is generally accepted that the overall rate-limiting step [31] for P450-mediated mono-oxygenase activity is determined by the second
reduction process stage, and this is consistent with the information presented above for both bacterial and microsomal systems. For
example, an electron transfer rate of 30^33 s31 in CYP101 would correspond closely with the turnover of 1800^1900 min31 quoted
for this system. Putidaredoxin is reduced via putidaredoxin reductase, whereas cytochrome b5 is reduced via cytochrome b5 reductase;
both FAD-containing reductases are NADH-dependent. References: [6,12,14,22,32^34].
aData produced in reconstituted systems which did not employ the natural redox partner, putidaredoxin.
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possess cysteine proximal ligands with sulfur ligating
the heme iron, as it does in the cytochromes c.
Clearly, the changes in heme ligands have a strong
bearing on the redox properties of these various he-
moproteins, despite the fact that heme surface area
exposed to solvent correlates well (r = 0.96) with iron
redox potential. However, assuming that one can
extrapolate this relationship to CYP101, for example,
it is possible to demonstrate that the binding of cam-
phor to the substrate-free enzyme would result in a
15% decrease in heme exposed to the aqueous envi-
ronment according to the change in hemoprotein re-
dox potential, and this is borne out by calculations
on the crystal structures of substrate-bound and sub-
strate-free CYP101 [23] where the percentage heme
exposures are 32.3% and 48.6%, respectively.
Kassner has derived an expression based on the
Born equation for explaining the di¡erence (vEo) in
hemoprotein redox potential relative to that of the
aqueous Fe2/Fe3 couple [39]. This relationship in-
dicates that the variations in redox potential for he-
moproteins is dependent on the local dielectric con-
stant of the medium relative to that of water as well
as on the radius of the protein relative to that of the
heme moiety as follows:
vEo  Nz
2e2
4ZO oU2nF
1
r1
3
1
r2
 
1
DN
3
1
DP
 
where N is the Avogadro constant, z is the net over-
all charge on the ion, e is the electronic charge, Oo is
the permittivity of free space, n is the number of
electrons involved in the process, F is the Faraday
constant, r1 and r2 are the radii of the heme and
hemoprotein, respectively, whereas DN and DP are
the dielectric constants of the nonpolar and polar
environments, respectively. In the case of P450,
both n and z are unity, whereas the equality F = eN
further simpli¢es the constant term in the above ex-
pression, which becomes, after the evaluation of fun-
damental constants, to the following:
vEo  7:1998 1
r1
3
1
r2
 
1
DN
3
1
DP
 
where the units are Angstroms for the radii of heme
and protein to give vEo in volts.
Utilizing this expression for the calculation of the
di¡erence in redox potential between a hemoprotein
like P450 and the standard Fe2/Fe3 couple in
aqueous solution involves the employment of the
following data:
Eo for Fe2/Fe3 = 0.771 V at 25‡C; Fe2 (low-
spin) radius = 0.61 Aî (and z = 2 for Fe2) ; Fe (por-
phyrin) radius = 6.78 Aî in heme; dielectric constant
of water = 78.54; local dielectric constant = 28 for the
surface of a protein [40].
Putting these values into the above equation for
the change in redox potential, vEo, gives:
vEo  28:7993 1
0:61
3
1
6:78
 
1
28
3
1
78:54
 
 0:9874 V
LEoheme  0:77130:987  30:216 V at 25C
This result compares favorably with the value of
30.225 volts for CYP2B4, which is a typical example
of a microsomal P450. One can also use the Kassner
expression to calculate the likely change in redox
potential, which occurs when a substrate binds to
P450, on the basis of a diminution of the local di-
electric constant. If one assumes that the substrate-
bound active site has a dielectric constant of 4 for a
protein interior [40] and, using 16Aî as an average
value for the radius of the P450 hemoprotein based
on the CYP101 crystal structure, the Kassner equa-
tion can be formulated as:
vEo  7:1998 1
6:78
3
1
16
 
1
4
3
1
28
 
 0:131 V at 25C
In fact, the di¡erence between the redox potential of
substrate-free and substrate-bound P450cam is 0.130
Table 4
Heme exposure and redox potential in hemoproteins
Hemoprotein % Exposure Eo
0
Fe3=Fe2
Cytochrome c2 6 320
Cytochrome c 4 260
Cytochrome c550 5 250
Hemoglobin K 14 113
Hemoglobin L 20 53
Myoglobin 18 47
Cytochrome b5 23 20
Correlation equation for the above data: Eo
0
= 343.88^14.94%
(þ 1.95) exposure; n = 7; s = 37.36; R = 0.96; F = 46.0.
According to the above relationship, the binding of camphor to
CYP101 would give rise to a lowering of heme area exposed to
solvent from about 50% to 35%. References: [23,37,38].
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V, which is in excellent agreement with the calculated
value.
For a microsomal P450, such as CYP2B4, the
change in redox potential on substrate binding is
only 0.0748 V, however, and this could be due to
the increased hydrophobic environment at the pro-
tein surface (due to membrane binding) coupled with
a greater local dielectric constant at the heme pocket
relative to the situation in P450cam (CYP101). There
is also a likelihood that the hemoprotein radius is
somewhat greater in CYP2B4 than CYP101, which
would conform with the increased molecular mass of
the microsomal P450. According to the above expres-
sion, a local dielectric constant of 6.25 (elevated
slightly due to the ingress of water molecules)
coupled with a surface dielectric constant of 26.5 is
consistent with a change in redox potential of 0.0748
V, assuming that the hemoprotein radius approxi-
mates to 16 Aî . Bearing in mind the di¡erence be-
tween CYP101 and CYP2B4 in terms of the hydro-
phobic environment both within the heme pocket
and that experienced by the whole enzyme, it is pos-
sible that these modi¢ed dielectric constants are not
unrealistic. Consequently, it is possible to provide a
rational explanation for the redox potential of P450s
which also yields quantitative estimates that are close
to the experimental values, despite a number of as-
sumptions being made.
2.3. Coupling of spin and redox equilibria
As mentioned previously, there is a linkage be-
tween the modulation of hemoprotein spin state
and redox potential in certain P450 systems, which
has been shown to conform closely with the theoret-
ical treatment as described by Sligar [41] and by Sli-
gar and Gunsalus [42]. According to theory, there
should be a linear correlation between substrate-
mediated perturbation of the P450 ferriheme spin
equilibrium (favoring the shift to high-spin) and in-
crement of the hemoprotein redox potential. The der-
ivation of the following expression, based on an ap-
plication of the Nernst equation to the P450 system,
can be formulated as:
Eo
0  RT
F
lnK redox3
RT
F
ln
1 K spin
K spin
 
where Eo
0
is the observed redox potential, R is the
gas constant, T is the absolute temperature, F is the
Faraday constant, Kredox is equilibrium constant be-
tween Fe2 and Fe3, whereas ln symbolizes natural
logarithms and Kspin is the equilibrium constant be-
tween high- and low-spin Fe3 P450.
The above equation can be rearranged so that
evaluation of the constant terms for a temperature
of 298 K gives the following expression:
Eo
0  25:68lnK redox  25:68lnHS fraction
where HS denotes the high-spin state of the hemo-
protein.
Accordingly, one can expect a linear relationship
between redox potential and percentage high-spin
component (expressed as the log of the high-spin
fraction) which is of gradient equal to 25.68 and
possessing an intercept on the y-axis that is consis-
tent with the redox potential of high-spin P450. In
fact, this is found to be the case, yielding an intercept
value of 3174 mV which is very close to the data for
Table 5
Coupling of spin and redox equilibria in P450s
CYP % HS Kspin Eo
0
(mV) Kredox
101 8 0.089 3303 1.2U105
101+camphor 94 14.4 3173 8.0U102
2B1 10 0.113 3300 1.2U105
2B1+hexobarbital 35 0.549 3237 9.4U103
2B1+benzphetamine 38 0.607 3225 5.9U103
Correlation equations n s R F
%HS  0:610:11Eo0  187:1 5 11.76 0.96 31.9
logK spin  3:5430:910:15logK redox 5 0.27 0.96 31.9
References: [23,43,44].
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high-spin CYP101 (i.e., 3173 mV). Table 5 provides
the relevant data for CYP101 and CYP2B1, where
there is an excellent correlation (r = 0.96) between
redox potential and percentage high-spin component.
Expressing these values in terms of the corresponding
equilibrium constants, Kspin and Kredox, for the hemo-
protein spin-state and redox equilibria respectively,
also provides a satisfactory correlation (r = 0.96) be-
tween the data, albeit for only a small number of
observations. However, similar results have been re-
ported for benzphetamine analogues binding to mi-
crosomal P450s [45^48] where there are also correla-
tions between spin-state equilibria and rates of both
P450 reduction and substrate metabolism. Moreover,
there are often very good correlations between the
reduction rate constant for microsomal P450 and
percentage high-spin component following substrate
binding [16,49], thus indicating that the extent of
substrate binding brings about a modulation in the
P450 spin equilibrium (favoring the high-spin state)
which appears to be coupled with the rate of electron
transfer or reduction of the P450 when substrate-
bound [50]. It is also apparent that there is a sub-
strate-dependent competition of di¡erent P450s for
reductase [51] in the microsomal system. This indi-
cates that the binding of preferred substrates to a
particular P450 isoform will bring about optimal in-
teraction with reductase, thus leading to e⁄cient sub-
strate turnover, and that this is linked with the extent
of coupling between spin and redox equilibria.
Related ¢ndings have been observed with the bac-
terial isoform, P450cam (CYP101) in that, for exam-
ple, the rate constant for reduction exhibits a paral-
lelism with the hemoprotein redox potential for a
series of substrate analogues [52]. Table 6 shows
the relevant data for seven compounds, including
the endogenous substrate, camphor, and structurally
related ketones. In this case, it is found that the
logarithm of the reduction rate constant correlates
closely (r = 0.992) with the experimentally determined
redox potential of the hemoprotein (see Fig. 1).
Although the relevant data is not shown in Table
6, it has also been reported that there is a good
correlation between spin-state modulation and redox
potential in substrate-bound CYP101 [52]. Further-
more, it would appear that the binding of substrates
to CYP101 has an e¡ect on the disposition of tyro-
sine residues, possibly in the active site region, which
is suggestive of a substrate-induced conformational
change in the P450, because there is a linkage
(r = 0.975) between modulation of the spin-state equi-
librium and the number of tyrosine residues exposed
when substrates bind [53]. It is apparent from these
¢ndings that the binding of substrates to CYP101
reduces the extent of tyrosine exposure in a manner
which brings about a concomitant increase in the
high-spin component of the P450. Presumably, the
e¡ect of preferred substrate binding to CYP101 in-
volves interaction with Tyr96 in particular, as this is
Table 6
Reduction rate constant and redox potential in CYP101
Compound k (s31) log k Eo
0
(mV)
1. TMCHa 0.7 30.1549 3242
2. Norcamphor 5.1 0.7076 3206
3. D-Fenchone 6.0 0.7782 3208
4. D-3-Bromocamphor 8.0 0.9031 3197
5. L-Camphorquinone 30.0 1.4771 3183
6. Adamantanone 43.0 1.6335 3175
7. D-Camphor 84.0 1.9243 3170
Correlation equation for the above data:
log k = 0.028 Eo
0
+6.611; n = 7; s = 0.1001; R = 0.992; F = 232.3.
Fig. 1 shows the graph of log k versus Eo
0
for the seven com-
pounds listed above. There is also a correlation between the
logarithm of the spin-state equilibrium constant and redox po-
tential of ferric P450cam (CYP101). Reference: [52]
aTMCH, tetramethylcyclohexanone.
Fig. 1. A plot of log k versus Eo
0
for camphor analogues bind-
ing to P450cam based on the data presented in Table 6.
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374 359
the only tyrosine residue close to the heme in this
P450 isoform. For example, the crystal structure of
camphor-bound CYP101 shows that the substrate is
able to form a hydrogen bond between its carbonyl
oxygen atom and the phenolic hydroxyl group on
Tyr96 [54] although this has not been proven un-
equivocably. The inference from these ¢ndings
points, however, to the likelihood of substrate inter-
action with Tyr96, probably involving hydrogen
bonding in most cases, which is also associated
with substrate-mediated desolvation of the heme en-
vironment of CYP101 that brings about the shift to
predominantly high-spin P450, especially for sub-
strates possessing signi¢cant structural similarity
with camphor.
3. Structural features and the rates of electron
transfer and substrate turnover
Clearly, one factor associated with P450 substrate
turnover rate involves the electron transfer from re-
dox partner to the P450 enzyme itself [55]. This is
probably dependent on the distance between the in-
teracting centers on the two components and the
intervening medium, together with the concentra-
tions of both P450 and redox partner in the cell
type under consideration; although the rate of elec-
tron transfer is also partially dependent on the redox
potentials of the P450 and its redox partner, as men-
tioned previously. In addition, the electron transfer
pathway involved will a¡ect its e⁄ciency, and there
is speculation that the presence of intervening aro-
matic residues and/or hydrogen-bonded conduits
play a key role in electron pathways within the
P450 system. For example, Gerber and Sligar
[56,57] have shown that there is evidence for a distal
charge relay operating in the CYP101 system, where-
by ion-paired interactions in the vicinity of the active
site may be involved in channelling protons via in-
tervening protein-bound water molecules. Addition-
ally, Shimizu [58] has reviewed the evidence from
site-directed mutagenesis experiments which point
to a possible role of conserved aromatic residues in
electron transfer within various P450s, such as a con-
served proximal phenylalanine in CYP101 [59]. Fur-
thermore, Raag and Poulos [60] have suggested that
Glu366 in CYP101 could be involved in facilitating
the ingress of protons to the active site via a hydro-
gen bond network linking this proximal acidic resi-
due with the conserved distal threonine (Thr252).
Structural studies on the CYP101 system [61] indi-
cate that there is a channel of hydrogen-bonded
water molecules connecting Thr252 in the I helix
with Glu366 in the L helix, which is part of the gen-
erally accepted region for putidaredoxin binding in
CYP101 [20,62]. These features are highly conserved
in many P450s, including microsomal isoforms and it
is possible, therefore, that hydrogen-bonded water
channels are associated with proton transfer from
the protein surface to the heme environment; indeed,
this hypothesis has increasing support from site-di-
rected mutagenesis data, and there is evidence for a
critical role of protein-bound water molecules in the
CYP101 system [63].
Alternatively, hydrogen bond conduits for proton
and/or electron transfer in the P450 system could
involve conserved K-helical elements, such as the I
helix which links putative redox partner binding sites
with the active site region (reviewed in [23,64]). For
example, a pair of conserved basic residues situated
towards the C-terminus of the G helix appear to be
mediators in the transmission of conformational
changes resulting from reductase binding, involving
a conserved ion-pair with an acidic residue at the N-
terminus of the H helix and a second salt-bridge
connecting the second basic residue with the start
of the I helix (reviewed in [64]). Although these elec-
trostatic contacts may have a structural role in main-
taining the tertiary fold, evidence from site-directed
mutagenesis [65] and chemical modi¢cation [66,67]
suggests that they are associated with reductase in-
teraction (and subsequent reduction) in microsomal
P450s. Moreover, a possible role for certain key hel-
ical segments in P450s could involve a substrate-in-
duced scissoring movement which may trigger or fa-
cilitate redox partner binding, and similar instances
have been suggested in other hemoproteins [24].
The I and L helices represent likely candidates for
this e¡ect as they are optimally located distal and
proximal to the heme moiety, respectively, although
a portion of L-sheet lying close to the active site
could also participate, especially as this segment (L2
in CYP102) contains a favored reductase site
(Lys349) at its surface region [23]. In fact, several
site-speci¢c mutagenesis studies within this area
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have shown that substrate binding and metabolism
can be a¡ected by residue modi¢cation (reviewed in
[68]).
However, it is clear that basic residues on P450 are
important for ion-paired interactions with redox
partners in both prokaryotic and eukaryotic systems,
as has been mentioned previously. Essentially, these
electrostatic contacts are involved in ‘steering’ the
redox interaction, whereas the relevant aromatic ami-
no acids appear to lie within the sphere of these key
salt bridges such that they may mediate electron
transfer to the heme. Moreover, there are some res-
idues which are both basic and aromatic, such as
histidine and tryptophan, that may in addition
form hydrogen bond interactions with other amino
acids or the heme itself, and some of these have been
identi¢ed in both microsomal [69,70] and bacterial
P450 systems [32]. For example, His355 in CYP101
forms a central part of what can be described as a
proximal charge relay between Ser83 and one of the
heme propionates [23,64]. As there is a hydrogen
bond network linking this system with a surface ly-
sine (Lys314), which could be a contact point for
putidaredoxin reductase, it is possible that the charge
relay system has a role in electron transfer between
putidaredoxin and CYP101. Interestingly, there is a
strong conservation of a basic residue proximal to
the heme (at two positions upstream of the invariant
cysteine) in the majority of P450s, which could play a
role in facilitating the access of water to the heme
[71] and the surface lysine mentioned previously is
also highly conserved in most isoforms (reviewed in
[23,64]).
Another well-conserved residue thought to be in-
volved in electron transfer [72] is represented by
Trp96 in CYP102, although it may also play a role
in heme binding (reviewed in [68]). The majority of
microsomal and other eukaryotic P450s possess a
key tryptophan residue, corresponding to Trp96 in
CYP102, in the putative C helix lying close to the
heme and, in the CYP102 structure, this residue
forms a hydrogen bond with one of the heme propi-
onate groups. Trp96 is also a surface residue in the
crystal structure of CYP102, where it may be in-
volved [73] in transferring electrons from reductase
to the heme moiety or in association of the heme
prosthetic group [74], and modeling of this interac-
tion also indicates this possibility, as shown in the
following section. Apart from CYP102, this residue
is absent in prokaryotic P450s but, in the CYP101
redox partner putidaredoxin [75], there is a C-termi-
nal tryptophan (Trp106) which has been shown to
participate in electron transfer (reviewed in [76]).
The inference which may be drawn from these ¢nd-
ings is that incorporation of the conserved trypto-
phan occurred during the evolutionary development
of the microsomal and other eukaryotic P450 sys-
tems, where it can perhaps regulate more precisely
the electron transfer process from the reductase £a-
voprotein, as opposed to the relatively primitive
iron^sulfur redoxin encountered in most prokaryotic
P450 redox pathways (and in the mitochondrial sys-
tem), and the change to a membrane-bound environ-
ment in eukaryotes could be of relevance to utiliza-
tion of a trytophan in the hemoprotein rather than in
the redox partner as encountered in bacterial P450s
(reviewed in [23]).
It is possible to formulate an expression for reduc-
tion rate in, for example, the microsomal system
based on a kinetic and thermodynamic theory [14]
as follows:
Reduction rate  KakETP450 Fpt
where Ka is the association constant between the
P450 and reductase £avoprotein of concentrations
[P450] and [Fpt], respectively, and kET is the rate
constant for electron transfer. Some relevant data
for dissociation constants and electron transfer rates
are provided in Table 3. This means that for a Kd of
0.07 WM between reductase and CYP2B4, for exam-
ple, and with concentrations of reductase and P450
of 2U1034 M and 1034 M, respectively, the rate of
reduction will be about 2^3 s31 based on an electron
transfer rate constant of 10 s31 [14]. In fact, such a
¢gure is fairly consistent with the experimentally ob-
served values for overall reduction rates in microso-
mal P450 systems, and this accords well with exper-
imental data on typical substrate turnover. Table 7
shows that there is a substantial variation in turnover
rates between di¡erent P450 systems, and one factor
is likely to be due to the change in rate constant for
electron transfer. Clearly, the distance between inter-
acting electron donor/acceptor centers on redox com-
ponents is important, and the Marcus equation can
be used for evaluation of rates in such systems (re-
viewed in [24]). This equation is of the form:
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lnk  lnQ ET3 V3vE
o 2
4kBVT
where k is the rate constant for electron transfer, QET
is the limiting rate at in¢nite temperature, kB is the
Boltzmann constant, V is the relaxation energy of the
reaction, T is the absolute temperature, and vEo is
the di¡erence in redox potential between electron
donor and acceptor centers. It can be readily appre-
ciated that the above expression is essentially a quad-
ratic in vEo and, consequently, there should be a
parabolic relationship between the logarithm of the
electron transfer rate constant and the di¡erence in
redox potential of the two interacting species directly
involved in the electron transfer process, and such
relationships have been found in practice [77]. For
a reduction rate of 18 s31 in an electron transfer
between reductase and a microsomal P450 of concen-
trations 2U1034 M and 1036 M, respectively [14] a
dissociation constant of 0.1 WM between reductase
and P450 yields a value for the rate constant of elec-
tron transfer as 9U103 s31. Such a ¢gure suggests
that the distance [24] between the two interacting
centers is between 15 and 20 Aî , which is in good
agreement with the suggested orientation for the
P450-reductase interaction complex [78]. It should
also be appreciated that the e¡ect of the delocalized
porphyrin iron ligand in a heme moiety extends the
range of the iron atom by about 5 Aî , as electron
‘jumps’ may occur between edges of the heme in,
for example, the cytochrome b5^P450 complex [20].
Another aspect of electron transfer rates is the re-
dox potential di¡erence between the interacting spe-
cies, and Table 7 presents some relevant information
on the redox potentials and turnover numbers in
typical P450 systems. Although the Marcus equation
indicates a quadratic relationship between rate and
redox potential di¡erence, it is possible that the
rather limited data presented in Table 7 re£ect only
a portion of the overall parabolic plot, thus giving
the appearance of an essentially linear relationship. It
is also possible to demonstrate that the redox poten-
tial of the redox partner itself has a bearing on over-
all turnover rates, which, although the data available
in Table 7 is somewhat limited, suggests that the
more negative the redox potential, the faster the
rate. However, other factors, such as distance and
dielectric constant of the intervening medium, are
also important (reviewed in [5]). For example, the
inter-heme distance in the modeled interaction be-
tween cytochrome b5 and CYP101 of about 12^14
Aî would be consistent with a rate constant of around
105 s31, whereas outer sphere distances in the region
of 4 Aî are likely to give rise to higher transfer rates
of about 1010 s31 [79]. The distances between inter-
acting centers in reductase are relatively large, but
these are compensated by intervening aromatic resi-
dues, which can provide a means for electron-tunnel-
ing [80] to occur and, as mentioned previously, there
is a likelihood that similar processes occur within
P450s also. It is recognized that a 4 Aî gap between
aromatic rings is required for electron transfer via
the overlap of the two Z-systems, whereas a distance
of 15 Aî is common for hydrogen-bonded conduits in
Table 7
Redox potentials and substrate turnover
Redox grouping Eo (mV) CYP Turnover (min31) Substrate
FMN (reductase) 3270 102 4600 Pentadecanoic acid
Fe2S2 (Pdx) 3196 (3240) 101 1900 Camphor
Heme (b5) +25 2b4 29 Benzphetamine
Donor Eredox (mV) EP450 (mV) vEo (mV)
Pdx 3240 3170 70 101 34 Camphor
Adx 3290 (3296) 3280 (3287) 10 (9) 11A1 1.67 Cholesterol
Fpt 3270 3263 7 2B4 1.42 Hexobarbital
Pdx, putidaredoxin; Adx, adrenodoxin; b5, cytochrome b5 ; Fpt, £avoprotein; vEo, EP4503Eredox ; EP450, P450 redox potential (sub-
strate-bound); Eredox, redox partner potential. It is found that log turnover gives a linear relationship with vEo and an inverse rela-
tionship with redox partner potential for the three di¡erent types of P450 considered. Values in parentheses have also been reported
in the literature. References to data: [4,5,12,14,23].
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proteins [24] and clearly both mechanisms are feasi-
ble in P450 redox systems. Moser and Dutton [81]
has shown that there is an inverse linear relationship
between the logarithm of the electron transfer rate
constant and distance between interacting species for
a number of protein systems. Substituting a typical
value for the rate constant in CYP102 [82] for £avin
to heme electron transfer, into this expression, gives
a value of 21 Aî for the relevant distance, and is in
good agreement with the recent crystallographic data
[83,84].
The most probable explanation for the high rate of
substrate turnover in CYP102, therefore, is that the
hemoprotein and reductase domains are covalently
linked into a single fused system. In fact, it appears
that the FMN and heme moieties are positioned rel-
atively close (V20 Aî ) in CYP102, as evidenced from
the crystal structure of the FMN domain^hemopro-
tein complex [83,84], although it should be appreci-
ated that this proteolyzed form may not adequately
re£ect the true situation in vivo. A close analogy to
this system is a¡orded by £avocytochrome b2 which
has also been resolved crystallographically [85]. In
the £avocytochrome b2 structure, it appears that a
tyrosine residue (Tyr143) bridges the gap between
FMN and heme moieties, thus indicating that inter-
vening aromatic residues probably participate in
many electron transfer reactions, and it has been
reported [86] that the reaction of hydrated electrons
with hemoproteins is partly dependent on the num-
ber of aromatic amino acids in the protein. However,
in the case of £avocytochrome b2, mutagenesis of
Tyr143 [87,88] to phenylalanine has a marked e¡ect
on electron transfer such that one may assume, in
this example, that the inter-domain hydrogen bond
formed by the hydroxyl group of this residue plays a
role in structural integrity of the system by bringing
together the interacting FMN and heme moieties,
thus facilitating electron £ow between the two
groups, possibly via the mediation of an aromatic
ring once it has been ‘¢xed’ in the optimum position
for electron transfer.
4. The structures of redox partners in various P450
systems
There has been a growing interest in structural
characterization of the various redox components
in P450 systems in recent years, and several bacterial
Table 8
Structurally characterized P450s and thier redox partners
Species PDB codes References
Hemoproteins
Cytochrome b5 Bovine 3b5c [89]
Cytochrome P450cam P. putida 2cpp [54]
Cytochrome P450bm3 B. megaterium 2hpd [90]
Cytochrome P450eryF S. Polyspora 1oxa [91]
Cytochrome P450terp Pseudomonas spp. 1cpt [92]
Redoxinsa
Putidaredoxin* P. putida 1put [93^95]
Adrenodoxin Bovine 1ayf [96]
Reductases
Cytochrome b5 reductase Porcine 1ndh [97,98]
Ferredoxin reductase Spinach 2fnr [99,100]
P450 oxidoreductase Rat 1amo [101,102]
All the proteins listed are characterized as X-ray crystal structures except for Putidaredoxin (*) which represents an NMR structure
determination. However, the FMN domain of human P450 oxidoreductase has been investigated using NMR spectroscopic measure-
ments [103,104].
aOther redoxins have had their 3-D structures determined, and the two included here are speci¢cally involved in P450 redox path-
ways.
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P450 isoforms have been resolved crystallographi-
cally together with some of the known P450 redox
partners, as presented in Table 8. Consequently, oth-
er than those of eukaryotic P450s, many of the redox
components for both prokaryotic and microsomal
systems have had their three-dimensional structures
determined. Indeed, following the recent publication
of structural data for a mammalian cytochrome P450
oxidoreductase [101] there is now available most of
the elements in the microsomal P450 electron trans-
port chain due to the fact that cytochrome b5 and its
reductase have also had their structures determined
by X-ray crystallography [89,97,98]. However, the
relevant mammalian P450 isoforms have had to be
modeled by homology with one or more of the bac-
terial P450s that have had their three-dimensional
structures determined and, at present, it appears
that cytochrome P450BM3 (CYP102) represents the
most appropriate template for the generation of mi-
crosomal P450 models (reviewed in [23,64]).
4.1. The P450cam system
Cytochrome P450cam (CYP101) and its redox part-
ner, putidaredoxin, are both available for investiga-
tion of their likely interaction, and most studies point
to a topographical ¢t at the proximal heme face of
P450, where there is concavity ideally suited for pu-
tidaredoxin binding which, moreover, involves a
number of basic residues that may participate in
ion-pairing (reviewed in [105]). The interaction be-
tween CYP101 and cytochrome b5 has been studied
using a combination of molecular modeling and site-
directed mutagenesis, where electrostatic potential
energy surfaces on both partners match closely
[19,20,62,106], and similar ionic interactions are
also apparent in related redox proteins [107,108].
Furthermore, the determinants of electron transfer
from putidaredoxin to CYP101 have also been exten-
sively investigated [4,32,109^118]. Fig. 2 shows a pos-
sible mode of interaction between putidaredoxin and
Fig. 2. A representation of the association complex between putidaredoxin (blue green) and P450cam (cyan) showing the disposition of
acidic (red) and basic (blue) residues on the two proteins. The heme group of P450 is shown in magenta, whereas the location of the
iron^sulfur center in putidaredoxin is displayed in yellow and the C-terminal tryptophan (Trp106) is in orange.
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CYP101 which is consistent with the available evi-
dence from site-directed mutagenesis of residues on
both components, in that there is signi¢cant ion-pair-
ing between basic residues on CYP101 and comple-
mentary acidic sidechains on putidaredoxin. In par-
ticular, Arg72, Arg112, Lys344 and Arg364 on
CYP101 appear to be optimally distributed at the
periphery of the proximal heme face for electrostatic
contacts with certain acidic residues of putidaredox-
in, including Asp9, Asp34, Asp38 and Asp103.
These interactions orientate the redox partner such
that electron transfer can readily occur between the
Fe2S2 cluster of putidaredoxin and the heme iron of
CYP101 (reviewed in [4]). For example, the four
pairs of ionic contacts (listed in Table 9) form a
ring with the heme moiety at its center, and it is
possible that aromatic residues on both CYP101
and putidaredoxin could participate in transferring
electrons to P450 [4]. In particular, Phe350 in
CYP101 is optimally placed for mediating electron
transfer from putidaredoxin (see Fig. 2) via a Z^Z
contact with Trp106, although there may be a role
for at least one of the cysteine residues on the redox-
in for transferring charge [116]. Phe350 in CYP101
has been the subject of mutagenesis experiments [59],
where its alteration to leucine exhibits a deleterious
e¡ect on catalytic activity. As this phenylalanine is
highly conserved throughout the P450 superfamily, it
is likely that it possesses an important structural or
catalytic role; the corresponding residue in CYP2E1
(Phe429) has indeed been shown to have both cata-
lytic relevance and heme-binding activity [120]. A
second aromatic residue in CYP101, namely Tyr75,
has also been implicated in the putidaredoxin inter-
action [4], and this residue lies close to Phe350 in the
crystal structure of CYP101 [54] such that some form
of cooperative binding may occur, including Z-Z
stacking with Trp106 in putidaredoxin, as suggested
by the modeled complex shown in Fig. 2.
Baldwin et al. [116] have proposed a covalent
switching mechanism for the electron transfer pro-
cess in the CYP101 system which involves the par-
ticipation of the C-terminal tryptophan in putidare-
doxin. It is suggested that the location of Trp106
with respect to the nearby Fe2S2 center and another
cysteine residue points to a mechanism of electron
transfer which includes covalent bond formation,
although Bernhardt [4] has argued that this proposal
is not entirely consistent with evidence from site-di-
rected mutagenesis. However, the relatively high re-
dox potentials of tyrosine and tryptophan
(Eo = +0.94 V and +1.05 V), respectively, show that
these could represent radical mediators of electron
transfer to species such as FeNO (Eo = +1.0 to
+1.5 V) which may be the catalytically active form
of oxygenated P450 [24]. Consequently, it is possible
that aromatic residues such as tryptophan and tyro-
sine could ful¢l a role in the transmission of charge
between iron^sulfur redox centers in redoxins and
the heme moiety in P450, possibly with the involve-
ment of optimally sited cysteines, especially as there
is evidence for weak interactions between thiol
groups and aromatic rings [121]. In fact, aromatic
residues are likely to be involved in mediating elec-
tron transfer between the £avoprotein oxidoreduc-
tase and P450 in the microsomal system also, where
the importance of a conserved tryptophan close to
Table 9
Contact pairs between redox partners in two P450 systems
Residues on
CYP101
Residues on
putidaredoxin
Residues on
cytochrome b5
(a) CYP101^Putidaredoxin complex
Arg72 T Asp38 Glu48
Arg112 T Asp103 Asp60
Lys344 T Asp34 Glu44
Arg364 T Asp9 Heme propionate
(b) CYP2B4^Oxidoreductase complex
Arg140 T Glu229 Glu48TArg85
Lys251a T Glu411 Asp60TArg125,126
Arg253a T Glu414 Glu44TLys433
Arg262 T Glu202 HemeTArg443
Lys384a T Glu655
T denotes an ion-paired interaction. The C-terminal tryptophan
(Trp106) of putidaredoxin may also interact with either Glu360
or Arg112 on CYP101. Residues reported by Stayton et al. [20]
as being involved in ion-pairing to the basic residues on
CYP101 shown above. Trp121 on CYP2B4 may be involved in
a long-range interaction with the FMN on reductase via medi-
ating aromatic sidechains. Additional contacts between comple-
mentary residues include: Ser259 on CYP2B4 with Ser408 on
reductase, and Asn258 on CYP2B4 with Gln222 on reductase.
References: [4,20,23,66,67,119].
aResidues modi¢ed by Bernhardt et al. [66,67] and shown to af-
fect reductase binding. Arg140 lies adjacent to Lys139 which
has also been modi¢ed e¡ectively by these coworkers; whereas
the residue corresponding to Arg253 in CYP1A2 has been the
subject of mutagenesis experiments (reviewed in [4]).
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the heme has been mentioned previously. In Fig. 2,
Trp106 in putidaredoxin is positioned near to
Gln360 in CYP101, and Bernhardt [4] has suggested
that there could be a pathway for electron transfer
via this residue involving a ‘through-space’ jump of
3.4 Aî to the proximal heme ligand, Cys357. In this
context, the route of electron transport was com-
puted using a novel algorithm (Pathways II program)
which has also been employed for other redox sys-
tems [122^124], and this seemed to be consistent with
available evidence from the mutation of key residues
in the vicinity of the heme.
4.2. The mitochondrial P450 system
In the mitochondrial system, it is thought that the
intermediary redox partner, adrenodoxin, ‘shuttles’
between its FAD-dependent electron source, adreno-
doxin reductase [125], and the relevant P450
(CYP11A or CYP11B) over a relatively short dis-
tance within the mitochondrial membrane (reviewed
in [4,126]). Site-directed mutagenesis and chemical
modi¢cation studies on adrenodoxin ([127^130])
and P450scc (CYP11A1), the P450 involved in the
cholesterol side-chain cleavage [131^133] point to
the importance of electrostatic interactions between
complementary ion-paired residues on the redox
partners in this system (including Lys377 and
Lys381 in CYP11A1, for example), and a model of
the active site complex between adrenodoxin and its
reductase [134] has been proposed [135]. A molecular
model of the interaction between adrenodoxin and
CYP11A1 has also been proposed recently [119],
which is broadly consistent with the above experi-
mental information and bears some similarities with
the expected redox complex between putidaredoxin
and CYP101, as mentioned in the previous section
(see [4] for a review). Recent mutation studies [136^
139] on adrenodoxin have probed speci¢c areas of
the likely binding interaction with both CYP11A1
Fig. 3. A representation of the tertiary complex between CYP2B4 (blue green), cytochrome b3 (orange) and oxidoreductase (cyan) is
shown, where the basic (blue) and acidic (red) residues are displayed in all three proteins. The heme moieties are shown in magenta,
whereas the FAD and FMN cofactors in reductase are displayed in maroon.
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and CYP11B1, such that a more complete picture is
emerging. It is hoped, furthermore, that the X-ray
crystal structure of adrenodoxin [96] will be able to
shed further light on the likely interactions present in
the mitochondrial P450 redox system.
4.3. The hepatic microsomal P450 system
For microsomal P450s, the redox partner is a £a-
voprotein oxidoreductase which contains both FAD
and FMN domains for the sequential transfer of
electrons from NADPH [25], although the cyto-
chrome b5-dependent pathway, primarily involved
in the second reduction step, involves an FAD-con-
taining reductase (cytochrome b5 reductase) that
transfers electrons from NADH (reviewed in
[4,23,140^145]). Apart from a P450 component, all
of the partners in the redox chain have been struc-
turally characterized using X-ray crystallography,
and Table 8 summarizes the current status of these
structures, together with relevant references to this
subject. Fig. 3 shows a construction of the tertiary
complex between CYP2B4, cytochrome b5 and oxi-
doreductase, where the published crystal structures
of the two latter proteins have been employed to
generate a model of the redox interactions based
on complementary ¢tting with the microsomal P450
isoform generated by homology [78,146]. The
CYP2B4 model was constructed from the CYP102
hemoprotein domain for which the 3-D coordinates
are known [90,147], and it is generally accepted that
the bacterial CYP102 constitutes a representative
analogy with microsomal P450s due, in part, to their
similarity in redox partner requirement, as both types
of P450 utilize an NADPH-dependent, FAD- and
FMN-containing oxidoreductase £avoprotein. The
reduction kinetics of CYP102 have been investigated
[148^150], and electron transfer between the FAD
and FMN groupings as well as between FMN and
the CYP102 hemoprotein domain appears to show
analogies with that encountered in the microsomal
P450 system, although some di¡erences are also
known [87,88,151,152].
In a series of elegant experiments involving the
chemical modi¢cation of basic residues in CYP2B4,
at least ¢ve surface lysine and arginine residues have
been proposed to be involved with the oxidoreduc-
tase interaction, and these include: Lys139, Arg145,
Lys251, Arg253 and Lys349, respectively [66,67,153^
156]. The modeled interaction shown in Fig. 3 is
largely based on these ¢ndings, although the muta-
genesis and other experimental studies of Hlavica
and colleagues [33,65,70,157^165], Munro et al.
[73], Strobel and coworkers [166^168], together
with those of Shen and Kasper [169], Nisimoto
[170], Chang et al. [171] and Bridges et al. [172],
have also been taken into account. The site of cyto-
chrome b5 (obtained from the relevant crystal struc-
ture) interaction with CYP2B4 shown in Fig. 3 was
modeled using the extensive work of Schenkman and
coworkers [173^179] together with that of others
[15,19,20,62,106,171,180^184]. Table 9 summarizes
the major interactions between the CYP2B4 and var-
ious redox partners, namely oxidoreductase and cy-
tochrome b5 and Fig. 3 indicates the electrostatic
ion-pairing between basic residues on this P450 iso-
form and complementary acidic residues on both cy-
tochrome b5 and oxidoreductase. It is apparent from
this modeled interaction that the two redox partners
are able to ¢t closely at nearby (possibly overlap-
ping) sites on the P450, and there is generally good
agreement with the published experimental data.
Consequently, it would appear that the combination
of X-ray crystal structures, NMR data, site-directed
mutagenesis, chemical modi¢cation of amino acids
and molecular modeling may provide a good descrip-
tion of redox interactions in the P450 mono-oxygen-
ase system.
Acknowledgements
The ¢nancial support by GlaxoWellcome Research
and Development Ltd., Merck, Sharp and Dohme
Ltd., the European Union Biomed 2 programme
and the University of Surrey Foundation Fund and
Grant H1 1/15-1 from the Deutsche Forschungsge-
meinschaft is gratefully acknowledged. We would
also like to thank Bill Peterson, Sandeep Modi, An-
drew Munro, Rita Bernhardt and Steve Sligar for
helpful discussions and much useful information.
References
[1] D.R. Nelson, L. Koymans, T. Kamataki, J.J. Stegeman, R.
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374 367
Feyereisen, D.J. Waxman, M.R. Waterman, O. Gotoh, M.J.
Coon, R.W. Estabrook, I.C. Gunsalus, D.W. Nebert, P450
superfamily: update on new sequences, gene mapping, acces-
sion numbers and nomenclature, Pharmacogenetics 6 (1996)
1^42.
[2] D.F.V. Lewis, E. Watson, B.G. Lake, Evolution of the cy-
tochrome P450 superfamily: sequence alignments and phar-
macogenetics, Mutat. Res. 410 (1998) 245^270.
[3] K.N. Degtyarenko, A.I. Archakov, Molecular evolution of
P450 superfamily and P450-containing mono-oxygenase sys-
tems, FEBS Lett. 332 (1993) 1^8.
[4] R. Bernhardt, Cytochrome P450: structure, function and
generation of reactive oxygen species, Rev. Physiol. Bio-
chem. Pharmacol. 127 (1995) 137^221.
[5] D.F.V. Lewis, J.M. Pratt, The cytochrome P450 catalytic
cycle and mechanisms of substrate oxygenation, Drug
Metab. Rev. 30 (1998) 739^786.
[6] R.D. Gray, The molecular basis of electron transfer in cyto-
chrome P450 enzyme systems, Front. Biotransform. 7 (1992)
321^350.
[7] D. Mansuy, D. J.-P. Renaud, Heme-thiolate proteins di¡er-
ent from cytochromes P450 catalyzing monooxygenations,
in: P.R. Ortiz de Montellano (Ed.) Cytochrome P450, Ple-
num, New York, 1995, pp. 537^574.
[8] B.R. Crane, A.S. Arvai, R. Gachhui, C. Wu, D.K. Ghosh,
E.D. Getzo¡, D.J. Stuehr, J.A. Tainer, The structure of ni-
tric oxide synthase oxygenase domain and inhibitor com-
plexes, Science 278 (1997) 425^431.
[9] R.T. Ruettinger, L.-P. Wen, A.J. Fulco, Coding nucleotide,
5P-regulatory, and deduced amino acid sequences of P-
450BMÿ3, a single peptide cytochrome P-450: NADPH-
P450 reductase from Bacillus megaterium, J. Biol. Chem.
264 (1989) 10987^10995.
[10] S. Govindaraj, T.L. Poulos, The domain architecture of cy-
tochrome P450BM-3, J. Biol. Chem. 272 (1997) 7915^
7921.
[11] A.W. Munro, S. Da¡, S.K. Chapman, R.M. Cook, J.G.
Lindsay, J.R. Coggins, Kinetic analysis of P450BM3 from
Bacillus megaterium, in: Flavins and Flavoproteins, Univer-
sity of Calgary Press, Calgary, 1996, 467^470.
[12] A.W. Munro, M.A. Noble, S.N. Da¡, S.K. Chapman, Fla-
vocytochrome P450 BM3: electron transfer and its control in
a model P450, Biochem. Soc. Trans. 27 (1999) A29.
[13] D. Bray, S. Lay, Computer-based analysis of the binding
steps in protein complex formation, Proc. Natl. Acad. Sci.
USA 94 (1997) 13493^13498.
[14] A.I. Archakov, G.I. Bachmanova, Cytochrome P450 and
Active Oxygen, Taylor and Francis, London, 1990.
[15] P.P. Tamburini, G.G. Gibson, Thermodynamic studies of
the protein-protein interactions between cytochrome P-450
and cytochrome b5, J. Biol. Chem. 258 (1983) 13444^13452.
[16] P.P. Tamburini, G.G. Gibson, W.L. Backes, S.G. Sligar, J.B.
Schenkman, Reduction kinetics of puri¢ed rat liver cyto-
chrome P450. Evidence for a sequential reaction mechanism
dependent on the hemoprotein spin state, Biochemistry 23
(1984) 4526^4533.
[17] G.G. Gibson, P.P. Tamburini, Cytochrome P450 spin-state :
inorganic biochemistry of haem iron ligation and functional
signi¢cance, Xenobiotica 14 (1984) 27^47.
[18] J.D. Lipscomb, S.G. Sligar, M.J. Namtvedt, I.C. Gunsalus,
Autoxidation and hydroxylation reactions of oxygenated cy-
tochrome P450cam, J. Biol. Chem. 251 (1976) 1116^1124.
[19] P.S. Stayton, M.T. Fisher, S.G. Sligar, Determination of
cytochrome b5 association reactions, J. Biol. Chem. 263
(1988) 13544^13548.
[20] P.S. Stayton, T.L. Poulos, S.G. Sligar, Putidaredoxin com-
petitively inhibits cytochrome b5-cytochrome P-450cam asso-
ciation: A proposed molecular model for a cytochrome P-
450cam electron-transfer complex, Biochemistry 28 (1989)
8201^8205.
[21] A.W. Munro, M.A. Noble, K.L. Turner, S.K. Chapman,
The interaction of eukaryotic cytochrome b5 with £avocyto-
chrome P450BM3 from Bacillus megaterium, Biochem. Soc.
Trans. 26 (1998) 212S.
[22] K. Ruckpaul, H. Rein, J. Blanck, Regulation mechanisms of
the activity of the hepatic endoplasmic cytochrome P450,
Front. Biotransform. 1 (1989) 1^65.
[23] D.F.V. Lewis, Cytochromes P450: Structure, Function and
Mechanism, Taylor and Francis, London, 1996.
[24] N.C. Veitch, R.J.P. Williams, The molecular basis of elec-
tron transfer in redox enzyme systems, Front. Biotransform.
7 (1992) 279^320.
[25] T. Iyanagi, On the mechanisms of one- and two-electron
transfer by £avin enzymes, Chem. Scripta 27A (1987) 31^
36.
[26] J.B. Schenkman, D. Kupfer (Eds.), Hepatic Cytochrome
P450 Monooxygenase System, Pergamon, Oxford, 1982.
[27] J.B. Schenkman, H. Griem (Eds.), Cytochrome P450,
Springer, Berlin, 1993.
[28] F.P. Guengerich, W.W. Johnson, Kinetics of ferric cyto-
chrome P450 reduction by NADPH-cytochrome P450 reduc-
tase: rapid reduction in the absence of substrate and varia-
tions among cytochrome P450 systems, Biochemistry 36
(1997) 14741^14750.
[29] A.W. Munro, J.G. Lindsay, J.R. Coggins, S.M. Kelly, N.C.
Price, NADPH oxidase activity of cytochrome P450BM3 and
its constituent reductase domain, Biochim. Biophys. Acta
1231 (1995) 255^264.
[30] P.R. Ortiz de Montellano, Heme oxygenase mechanism: evi-
dence for an electrophilic ferric peroxide species, Accounts
Chem. Res. 31 (1998) 543^549.
[31] Y. Imai, R. Sato, T. Iyanagi, Rate-limiting step in the re-
constituted microsomal drug hydroxylase system, J. Bio-
chem. 82 (1977) 1237^1246.
[32] M.D. Davies, L. Qin, J.L. Beck, K.S. Suslick, H. Koga, T.
Horiuchi, S.G. Sligar, Putidaredoxin reduction of cyto-
chrome P-450cam : dependence of electron transfer on the
identity of putidaredoxin’s C-terminal amino acid, J. Am.
Chem. Soc. 112 (1990) 7396^7398.
[33] Y.D. Ivanov, I.P. Kanaeva, M.A. Eldarov, K.G. Skryabin,
M. Lehnerer, J. Schulze, P. Hlavica, A.I. Archakov, An
optical biosensor study of the interaction parameters and
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374368
role of hydrophobic tails of cytochrome P450 2B4, b5 and
NADPH-£avoprotein in complex formation, Biochem. Mol.
Biol. Int. 42 (1997) 731^737.
[34] P.R. Ortiz de Montellano (Ed.), Cytochrome P450, 2nd ed.,
Plenum, New York, 1995.
[35] F.P. Guengerich, Oxidation-reduction properties of rat liver
cytochromes P450 and NADPH-cytochrome P450 reductase
related to catalysis in reconstituted systems, Biochemistry 22
(1983) 2811^2820.
[36] S.G. Sligar, D.L. Cinti, G.G. Gibson, J.B. Schenkman, Spin
state control of the hepatic cytochrome P450 redox poten-
tial, Biochem. Biophys. Res. Commun. 90 (1979) 925^932.
[37] E. Stellwagen, Haem exposure as the determinate of oxida-
tion-reduction potential of haem proteins, Nature 275 (1978)
73^74.
[38] D.F.V. Lewis, Physical methods in the study of the active
site geometry of cytochromes P450, Drug Metab. Rev. 17
(1986) 1^66.
[39] R.J. Kassner, A theoretical model for the e¡ects of local
nonpolar heme environments on the redox potentials in cy-
tochromes, J. Am. Chem. Soc. 95 (1973) 2674^2677.
[40] P.R. Andrews, M. Tintelnot, Intermolecular forces and mo-
lecular binding, in: C. Hansch, P.G. Sammes, J.B. Taylor
(Eds.), Comprehensive Medicinal Chemistry, vol. 4, Quanti-
tative Drug Design, Pergamon, Oxford, 1990, pp. 321^
347.
[41] S.G. Sligar, Coupling of spin, substrate and redox equilibria
in cytochrome P450, Biochemistry 15 (1976) 5399^5406.
[42] S.G. Sligar, I.C. Gunsalus, A thermodynamic model of reg-
ulation: modulation of redox equilibria in camphor monox-
ygenase, Proc. Natl. Acad. Sci. USA 73 (1976) 1078^1082.
[43] G.G. Gibson, Cytochrome P450: from biophysics to phar-
macology, in: J. Gorrod (Ed.), Development of Drugs and
Modern Medicines, Ellis Horwood, Chichester, 1986, pp.
253^266.
[44] D.F.V. Lewis, Computer modelling of cytochromes P450
and their substrates: a rational approach to the prediction
of carcinogenicity, Front. Biotransform. 7 (1992) 90^136.
[45] J. Blanck, H. Rein, M. Sommer, O. Ristau, G. Smettan, K.
Ruckpaul, Correlations between spin equilibrium shift, re-
duction rate and N-demethylation activity in liver microso-
mal cytochrome P450 and a series of benzphetamine ana-
logues as substrates, Biochem. Pharmacol. 32 (1983) 1683^
1688.
[46] J. Blanck, O. Ristau, A.A. Zhukov, A.I. Archakov, H. Rein,
K. Ruckpaul, Cytochrome P450 spin state and leakiness of
the monooxygenase pathway, Xenobiotica 21 (1991) 121^
135.
[47] W. Schwarze, J. Blanck, O. Ristau, G.R. Janig, K. Pommer-
ening, H. Rein, K. Ruckpaul, Spin state control of cyto-
chrome P450 reduction and catalytic activity in a reconsti-
tuted P450LM2 system as induced by a series of
benzphetamine analogues, Chem.-Biol. Interact. 54 (1985)
127^141.
[48] D.R. Petzold, H. Rein, D. Schwarz, M. Sommer, K. Ruck-
paul, Relation between the structure of benzphetamine ana-
logues and their binding properties to cytochrome P450LM2,
Biochim. Biophys. Acta 829 (1985) 253^261.
[49] G.G. Gibson, Cytochrome P450 spin state: regulation and
functional signi¢cance, in: A.R. Boobis, J. Caldwell, F. De
Matteis, C.R. Elcombe (Eds.), Microsomes and Drug Oxi-
dations, Taylor and Francis, London, 1985, pp. 33^41.
[50] J.B. Schenkman, S.G. Sligar, D.L. Cinti, Substrate interac-
tion with cytochrome P450, Pharmacol. Ther. 12 (1981) 43^
71.
[51] G.F. Cawley, C.J. Batie, W.L. Backes, Substrate-dependent
competition of di¡erent P450 isozymes for limiting NADPH-
cytochrome P450 reductase, Biochemistry 34 (1995) 1244^
1247.
[52] M.T. Fisher, S.G. Sligar, Control of heme protein redox
potential and reduction rate: linear free energy relation be-
tween potential and ferric spin state equilibrium, J. Am.
Chem. Soc. 107 (1985) 5018^5019.
[53] S.G. Sligar, R.I. Murray, Cytochrome P450cam and other
bacterial P450 enzymes, in: P.R. Ortiz de Montellano
(Ed.), Cytochrome P450, Plenum, New York, 1986, pp.
429^503.
[54] T.L. Poulos, B.C. Finzel, A.J. Howard, High-resolution
crystal structure of cytochrome P450cam, J. Mol. Biol. 195
(1987) 687^700.
[55] C.S. Eyer, W.L. Backes, Relationship between the rate of
reductase-cytochrome P450 complex formation and the
rate of ¢rst electron transfer, Arch. Biochem. Biophys. 293
(1992) 231^240.
[56] N.C. Gerber, S.G. Sligar, Catalytic mechanism of cyto-
chrome P450: evidence for a distal charge relay, J. Am.
Chem. Soc. 114 (1992) 8742^8743.
[57] N.C. Gerber, S.G. Sligar, A role for Asp251 in cytochrome
P450cam oxygen activation, J. Biol. Chem. 269 (1994) 4260^
4266.
[58] T. Shimizu, Diverse role of conserved aromatic amino acids
in the electron transfer of cytochrome P450 catalytic func-
tions: site-directed mutagenesis studies, Recent Res. Dev.
Pure Appl. Chem. 1 (1997) 169^175.
[59] T. Yasukochi, O. Okada, T. Hara, Y. Sagara, K. Sekimizu,
T. Horiuchi, Putative functions of phenylalanine-350 of
Pseudomonas putida cytochrome P450cam, Biochim. Biophys.
Acta 1204 (1994) 84^90.
[60] R. Raag, T.L. Poulos, X-ray crystallographic structural
studies of cytochrome P450cam : factors controlling substrate
metabolism, Front. Biotransform. 7 (1992) 1^43.
[61] T.L. Poulos, J. Cupp-Vickery, H. Li, Structural studies on
prokaryotic cytochromes P450, in: P.R. Ortiz de Montellano
(Ed.), Cytochrome P450, Plenum, New York, 1995, pp. 125-
150.
[62] P.S. Stayton, S.G. Sligar, The cytochrome P-450cam binding
surface as de¢ned by site-directed mutagenesis and electro-
static modelling, Biochemistry 29 (1990) 7381^7386.
[63] C. Di Primo, S.G. Sligar, G. Hui Bon Hoa, P. Douzou, A
critical role of protein-bound water in the catalytic cycle of
cytochrome P-450 camphor, FEBS Lett. 312 (1992) 252^
254.
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374 369
[64] D.F.V. Lewis, Three-dimensional models of human and oth-
er mammalian microsomal P450s constructed from an align-
ment with P450102 (P450bm3), Xenobiotica 25 (1995) 333^
366.
[65] J. Schulze, M. Lehnerer, D.F.V. Lewis, P. Hlavica, Amino
acid residue Glu-250 has a functional role in the assembly of
rabbit liver microsomal cytochrome P450 2B4 (CYP2B4),
Biochem. Mol. Biol. Int. 44 (1998) 1147^1155.
[66] R. Bernhardt, R. Kraft, K. Ruckpaul, Molecular mechanism
of P450/reductase interaction, in: I. Schuster (Ed.), Cyto-
chrome P-450: Biochemistry and Biophysics, Taylor and
Francis, London, 1989, pp. 320^323.
[67] R. Bernhardt, H. Stiel, K. Ruckpaul, Distance between ly-
sine 384 and heme of cytochrome P-450 LM2 (P-450IIB4)
studied by £uorescence energy transfer measurements, Bio-
chem. Biophys. Res. Commun. 163 (1989) 1282^1289.
[68] D.F.V. Lewis, The CYP2 family: models, mutants and in-
teractions, Xenobiotica 28 (1998) 617^661.
[69] G.G. Gibson, P.P. Tamburini, Chemical modi¢cation of the
histidine residues for puri¢ed hepatic cytochrome P450: in-
£uence of substrate binding and the hemoprotein spin state,
Chem.-Biol. Interact. 58 (1986) 185^198.
[70] P. Hlavica, M. Lehnerer, M. Eulitz, Histidine residues in
rabbit liver microsomal cytochrome P450 2B4 control elec-
tron transfer from NADPH-cytochrome P450 reductase and
cytochrome b5, Biochem. J. 318 (1996) 857^862.
[71] T. Oprea, G. Hummer, A.E. Garcia, Identi¢cation of a func-
tional water channel in cytochrome P450 enzymes, Proc.
Natl. Acad. Sci. USA 94 (1997) 2133^2138.
[72] K. Inouye, M.J. Coon, Properties of the tryptophan residue
in rabbit liver microsomal cytochrome P450 isozyme 2 as
determined by £uorescence, Biochem. Biophys. Res. Com-
mun. 128 (1985) 676^682.
[73] A.W. Munro, K. Malarkey, J.S. Miles, Investigating the
function of cytochrome P450 BM-3: a role for the phyloge-
netically conserved tryptophan residue?, Biochem. Soc.
Trans. 21 (1992) 66S.
[74] A.W. Munro, K. Malarkey, J. McKnight, A.J. Thomson,
S.M. Kelly, N.C. Price, J.G. Lindsay, J.R. Coggins, J.S.
Miles, The role of tryptophan 97 of cytochrome P450BM3
from Bacillus megaterium in catalytic function, Biochem.
J. 303 (1994) 423^428.
[75] C. Romeo, N. Moriwaki, K.T. Yasunobu, I.C. Gunsalus, H.
Koga, Identi¢cation of the coding region for the putidare-
doxin reductase gene from the plasmid of Pseudomonas pu-
tida, J. Protein Chem. 6 (1987) 253^261.
[76] E.J. Mueller, P.J. Loida, S.G. Sligar, Twenty-¢ve years of
P450cam research, in: P.R. Ortiz de Montellano (Ed.), Cyto-
chrome P450, Plenum, New York, 1995, pp. 83^124.
[77] R.A. Marcus, N. Sutin, Electron transfers in chemistry and
biology, Biochim. Biophys. Acta 811 (1985) 265^322.
[78] D.F.V. Lewis, B.G. Lake, M. Dickins, P.J. Eddershaw,
M.H. Tarbit, P.S. Godlfarb, Molecular modelling of
CYP2B6, the human CYP2B isoform, by homology with
the substrate-bound CYP102 crystal structure: evaluation
of CYP2B6 substrate characteristics, the cytochrome b5
binding site and comparisons with CYP2B1 and CYP2B4,
Xenobiotica 29 (1999) 261^393.
[79] C.A. Stein, N.A. Lewis, G. Seitz, Long-range intervalence
electron tunneling through fully saturated systems, J. Am.
Chem. Soc. 104 (1982) 2596^2599.
[80] L.P. Olson, T.C. Bruice, Electron tunneling and ab initio
calculations related to the one-electron oxidation of
NAD(P)H bound to catalase, Biochemistry 34 (1995)
7335^7347.
[81] C.C. Moser, P.L. Dutton, Engineering protein structure for
electron transfer function in photosynthetic reaction centers,
Biochim. Biophys. Acta 1101 (1992) 171^176.
[82] A.W. Munro, S. Da¡, J.R. Coggins, J.G. Lindsay, S.K.
Chapman, Probing electron transfer in £avocytochrome
P450BM3 and its component domains, Eur. J. Biochem. 239
(1996) 403^409.
[83] I. Sevrioukova, H. Li, J.A. Peterson, T.L. Poulos, Structural
studies on cytochrome P450BMÿ3, Proceedings of the 12th
International Symposium on Microsomes and Drug Oxida-
tions, Montpellier, France, 14^20 July, 1998.
[84] I.F. Sevrioukova, H. Li, H. Zhang, J.A. Peterson, T.L. Pou-
los, Structure of a cytochrome P450-redox partner electron-
transfer complex, Proc. Natl. Acad. Sci. USA 96 (1999)
1863^1868.
[85] Z.-X. Xia, F.S. Mathews, Molecular structure of £avocyto-
chrome b2 at 2.4 Aî resolution, J. Mol. Biol. 212 (1990) 837^
863.
[86] B.B. Hasino¡, Quantitative structure-activity relationships
for the reaction of hydrated electrons with heme proteins,
Biochim. Biophys. Acta 829 (1985) 1^5.
[87] J.S. Miles, A.W. Munro, B.N. Rospendowski, W.E. Smith,
J. McKnight, A.J. Thomson, Domains of the catalytically
self-su⁄cient cytochrome P450BM3, Biochem. J. 288 (1992)
503^509.
[88] C.S. Miles, N. Rouviereformy, F. Lederer, F.S. Mathews,
G.A. Reid, M.T. Black, S.K. Chapman, Tyr-143 facilitates
interdomain electron transfer in £avocytochrome b2, Bio-
chem. J. 285 (1992) 187^192.
[89] F.S. Mathews, P. Argos, M. Levine, The structure of cyto-
chrome b5 at 2.0 Aî resolution, Cold Spring Harbor Symp.
Quant. Biol. 36 (1972) 387^395.
[90] K.G. Ravichandran, S.S. Boddupalli, C.A. Hasemann, J.A.
Peterson, J. Deisenhofer, Crystal structure of hemoprotein
domain of P450BM-3, a prototype for microsomal P450s,
Science 261 (1993) 731^736.
[91] J.R. Cupp-Vickery, T.L. Poulos, Structure of cytochrome
P450eryF involved in erythromycin biosynthesis, Struct.
Biol. 2 (1995) 144^153.
[92] C.A. Hasemann, K.G. Ravichandran, J.A. Peterson, J.
Deisenhofer, Crystal structure and re¢nement of cytochrome
P450terp at 2.3 Aî resolution, J. Mol. Biol. 236 (1994) 1169^
1185.
[93] T.C. Pochapsky, X.M. Ye, 1H NMR identi¢cation of a
L-sheet structure and description of folding topology in pu-
tidaredoxin, Biochemistry 30 (1991) 3850^3856.
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374370
[94] T.C. Pochapsky, G. Ratnaswamy, A. Patera, Redox-depen-
dent 1H NMR spectral features and tertiary structural con-
straints on the C-terminal region of putidaredoxin, Bio-
chemistry 33 (1994) 6433^6441.
[95] T.C. Pochapsky, X.M. Ye, G. Ratnaswamy, T.A. Lyons,
An NMR-derived model for the solution structure of oxi-
dized putidaredoxin, a 2-Fe, 2-S ferredoxin from Pseudo-
monas, Biochemistry 33 (1994) 6424^6432.
[96] A. Mueller, J.J. Mueller, H. Uhlmann, R. Bernhardt, U.
Heinemann, New aspects of electron transfer revealed by
the crystal structure of a truncated bovine adrenodoxin,
Adx (4-108), Structure 6 (1998) 269^280.
[97] H. Nishida, K. Inaka, K. Miki, Speci¢c arrangement of
three amino acid residues for £avin-binding barrel struc-
tures in NADH-cytochrome b5 reductase and other £avin-
dependent reductases, FEBS Lett. 361 (1995) 97^100.
[98] H. Nishida, K. Inaka, M. Yamanaka, S. Kaida, K. Ko-
bayashi, K. Miki, Crystal structure of NADH-cytochrome
b5 reductase from pig liver at 2.4 Aî resolution, Biochemis-
try 34 (1995) 2763^2767.
[99] P.A. Karplus, M.J. Daniels, J.R. Herriott, Atomic structure
of ferredoxin-NADP reductase: prototype for a structur-
ally novel £avoenzyme family, Science 251 (1991) 60^66.
[100] S. Sheri¡, J.R. Herriott, Structure of ferredoxin-NADP
oxidoreductase and the location of the NADP binding
site, J. Mol. Biol. 145 (1981) 441^451.
[101] M. Wang, D.L. Roberts, R. Paschke, T.M. Shea, B.S.S.
Masters, J.-J.P. Kim, Three-dimensional structure of
NADPH-cytochrome P450 reductase: prototype for
FMN- and FAD-containing enzymes, Proc. Natl. Acad.
Sci. USA 94 (1997) 8411^8416.
[102] S. Djordjevic, D.L. Roberts, M. Wang, T. Shea, M.G.W.
Camitta, B.S.S. Masters, J.J.P. Kim, Crystallization and
preliminary X-ray studies of NADPH-cytochrome P450 re-
ductase, Proc. Natl. Acad. Sci. USA 92 (1995) 3214^
3218.
[103] I. Barsukov, S. Modi, L.-Y. Lian, K.H. Sze, M.J.I. Paine,
C.R. Wolf, G.C.K. Roberts, 1H 15N and 13C NMR reso-
nance assignment, secondary structure and global fold of
the FMN-binding domain of human cytochrome P450 re-
ductase, J. Biomol. NMR 10 (1997) 63^75.
[104] S. Modi, L.Y. Lian, G.C.K. Roberts, G.C.M. Smith, M.
Paine, C.R. Wolf, Structural studies on FMN domain of
cytochrome P450 reductase, Biochem. Soc. Trans. 23 (1995)
476S.
[105] B.K. Hawkins, J.H. Dawson, Oxygen activation by heme-
containing mono-oxygenase. Active site structures and
mechanisms of action, Front. Biotransform. 7 (1992) 216^
278.
[106] S.G. Sligar, D. Filipovic, P.S. Stayton, Mutagenesis of cy-
tochromes P450cam and b5, Methods Enzymol. 206 (1991)
31^49.
[107] J.B. Matthew, P.C. Weber, F.R. Salemme, F.M. Richards,
Electrostatic orientation during electron transfer between
£avodoxin and cytochrome c, Nature 301 (1983) 169^
171.
[108] V. Coghlan, L.E. Vickery, Electron interactions stabilizing
ferredoxin electron transfer complexes, J. Biol. Chem. 267
(1992) 8932^8935.
[109] P.S. Stayton, S.G. Sligar, Structural microheterogeneity of
a tryptophan residue required for e⁄cient biological elec-
tron transfer between putidaredoxin and cytochrome P-
450cam, Biochemistry 30 (1991) 1845^1851.
[110] M.D. Davies, S.G. Sligar, Genetic variants in the putidar-
edoxin-cytochrome P-450cam electron-transfer complex:
identi¢cation of the residue responsible for redox-state-de-
pendent conformers, Biochemistry 31 (1992) 11383^11389.
[111] J.A. Peterson, D.M. Mock, Cytochrome P-450cam and pu-
tidaredoxin interaction during electron transfer, Acta Biol.
Med. German. 38 (1979) 153^162.
[112] N.C. Gerber, T. Horiuchi, H. Koga, S.G. Sligar, Identi¢-
cation of 2Fe-2S cysteine ligands in putidaredoxin, Bio-
chem. Biophys. Res. Commun. 169 (1990) 1016^1020.
[113] M.J. Hintz, J.A. Peterson, The kinetics of reduction of
cytochrome P-450cam by reduced putidaredoxin, J. Biol.
Chem. 256 (1981) 6721^6728.
[114] M.J. Hintz, D.M. Mock, L.L. Peterson, K. Tuttle, J.A.
Peterson, Equilibrium and kinetic studies of the interaction
of cytochrome P-450cam and putidaredoxin, J. Biol. Chem.
257 (1982) 14324^14332.
[115] S.G. Sligar, P.G. Debrunner, J.D. Lipscomb, M.J. Namt-
vedt, I.C. Gunsalus, A role of the putidaredoxin COOH-
terminus in P-450cam hydroxylations, Proc. Natl. Acad. Sci.
USA 71 (1974) 3906^3910.
[116] J.E. Baldwin, G.M. Morris, W.G. Richards, Electron trans-
port in cytochromes P-450 by covalent switching, Proc. R.
Soc. Lond. B 245 (1991) 43^51.
[117] H. Koga, Y. Sagara, T. Yaoi, M. Tsujimura, K. Naka-
mura, K. Sekimizu, R. Makino, H. Shimada, Y. Ishimura,
K. Yura, M. Go, M. Ikeguchi, T. Horiuchi, Essential role
of the Arg112 residue of cytochrome P450cam for electron
transfer from reduced putidaredoxin, FEBS Lett. 331
(1993) 109^113.
[118] M. Unno, H. Shimada, Y. Toba, R. Makino, Y. Ishimura,
Role of Arg112 of cytochrome P450cam in the electron trans-
fer from reduction putidaredoxin, J. Biol. Chem. 271 (1996)
17869^17874.
[119] D.F.V. Lewis, P. Lee-Robichaud, Molecular modelling of
steroidogenic cytochromes P450 from families CYP11,
CYP17, CYP19 and CYP21 based on the CYP102 crystal
structure, J. Steroid Biochem. Mol. Biol. 66 (1998) 217^233.
[120] T.D. Porter, Mutagenesis at a highly conserved phenylala-
nine in cytochrome P450 2E1 a¡ects heme incorporation
and catalytic activity, Biochemistry 33 (1994) 5942^5946.
[121] M. Levitt, M.F. Perutz, Aromatic rings act as hydrogen
bond acceptors, J. Mol. Biol. 201 (1988) 751^754.
[122] D.N. Beratan, J.N. Onuchic, J.N. Betts, B.E. Bowler, H.B.
Gray, Electron-tunneling pathways in ruthenated proteins,
J. Am. Chem. Soc. 112 (1990) 7915^7921.
[123] D.N. Beratan, J.N. Onuchic, J.R. Winkler, H.B. Gray,
Electron-tunneling pathways in proteins, Science 258
(1992) 1740^1741.
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374 371
[124] D.N. Beratan, J.N. Betts, J.N. Onuchic, Tunneling pathway
and redox state-dependent electronic couplings at nearly
¢xed distance in electron-transfer proteins, J. Phys. Chem.
96 (1992) 2852^2855.
[125] Y. Sagara, Y. Takata, T. Miyata, T. Hara, T. Horiuchi,
Cloning and sequence analysis of adrenoredoxin reductase
cDNA from bovine adrenal cortex, J. Biochem. 102 (1987)
1333^1336.
[126] J.D. Lambeth, Enzymology of mitochondrial side-chain
cleavage by cytochrome P450scc, Front. Biotransform. 3
(1990) 58^100.
[127] V. Coghlan, L.E. Vickery, Electron interactions stabilizing
ferredoxin electron transfer complexes, J. Biol. Chem. 267
(1992) 8932^8935.
[128] L.M. Geren, P. O’Brien, J. Stonehuerner, F. Millett, Iden-
ti¢cation of speci¢c carboxylate groups on adrenodoxin
that are involved in the interaction with adrenodoxin re-
ductase, J. Biol. Chem. 259 (1984) 2155^2160.
[129] J.D. Lambeth, L.M. Geren, F.M. Millett, Adrenodoxin in-
teraction with adrenodoxin reductase and cytochrome P-
450scc, J. Biol. Chem. 259 (1984) 10025^10029.
[130] F.S. Millett, L.M. Geren, Chemical modi¢cation of inter-
action between adrenodoxin and cytochrome P450scc,
Methods Enzymol. 206 (1991) 49^56.
[131] T.B. Adamovich, I.A. Pikuleva, V.L. Chashchin, S.A. Usa-
nov, Selective chemical modi¢cation of cytochrome P-450scc
lysine residues. Identi¢cation of lysines involved in the in-
teraction with adrenodoxin, Biochim. Biophys. Acta 996
(1989) 247^253.
[132] A. Wada, M.R. Waterman, Identi¢cation by site-directed
mutagenesis of two lysine residues in cholesterol side chain
cleavage cytochrome P450 that are essential for adrenodox-
in binding, J. Biol. Chem. 267 (1992) 22877^22882.
[133] I.V. Turko, T.B. Adamovich, N.M. Kirillova, S.A. Usanov,
V.L. Chashchin, Cross-linking studies of the cholesterol
hydroxylation system from bovine adrenocortical mito-
chondria, Biochim. Biophys. Acta 996 (1989) 37^42.
[134] I. Hanukoglu, T. Gut¢nger, cDNA sequence of adrenodox-
in reductase: identi¢cation of NADP-binding sites in oxi-
doreductases, Eur. J. Biochem. 180 (1989) 479^484.
[135] T. Hara, T. Kimura, Active complex between adrenodoxin
reductase and adrenodoxin in the cytochrome P-450scc re-
action, J. Biochem. 105 (1989) 601^605.
[136] H. Uhlmann, S. Iametti, G. Vecchio, F. Bonomi, R. Bern-
hardt, Pro108 is important for folding and stabilization of
adrenal ferredoxin, but does not in£uence the functional
properties of the protein, Eur. J. Biochem. 248 (1997)
897^902.
[137] T.V. Burova, V. Beckert, H. Uhlmann, O. Ristau, R. Bern-
hardt, W. Pfeil, Conformational stability of adrenodoxin
mutant proteins, Protein Sci. 5 (1996) 1890^1897.
[138] V. Beckert, R. Bernhardt, Speci¢c aspects of electron trans-
fer from adrenodoxin to cytochromes P450scc and P45011L,
J. Biol. Chem. 272 (1997) 4883^4888.
[139] R. Bernhardt, R. Kraft, H. Uhlmann, V. Beckert, Investi-
gation of protein^protein interactions in mitochondrial ste-
roid hydroxylase systems using site-directed mutagenesis,
in: M.Z. Atassi, E. Apella (Eds.), Methods in Protein
Structure Analysis, Plenum, New York, 1995, pp. 283^
293.
[140] R. Bernhardt, Chemical probes of cytochrome P450 struc-
ture, in: J.B. Schenkman, H. Griem (Eds.), Cytochrome
P450, Springer, Berlin, 1993, pp. 547-560.
[141] W.L. Backes, NADPH cytochrome P450 reductase: func-
tion, in: J.B. Schenkman, H. Griem (Eds.), Cytochrome
P450, Springer, Berlin, 1993, pp. 15^34.
[142] S.D. Black, M.J. Coon, Structural features of liver micro-
somal NADPH-cytochrome P-450 reductase, J. Biol. Chem.
257 (1982) 5929^5938.
[143] T.D. Porter, C.B. Kasper, Coding nucleotide sequence of
rat NADPH-cytochrome P-450 oxidoreductase cDNA and
identi¢cation of £avin-binding domains, Proc. Natl. Acad.
Sci. USA 82 (1985) 973^977.
[144] T.D. Porter, C.D. Kasper, NADPH-cytochrome P450 oxi-
doreductase: £avin mononucleotide and £avin adenine di-
nucleotide domains evolved from di¡erent proteins, Bio-
chemistry 25 (1986) 1683^1687.
[145] T.D. Porter, T.W. Beck, C.B. Kasper, NADPH-cyto-
chrome P-450 oxidoreductase gene organization correlates
with structural domains of the protein, Biochemistry 29
(1990) 9814^9818.
[146] D.F.V. Lewis, B.G. Lake, Molecular modelling of mamma-
lian CYP2B isoforms and their interactions with substrates,
inhibitors and redox partners, Xenobiotica 27 (1997) 443^
478.
[147] H. Li, T.L. Poulos, The structure of the cytochrome
P450BM-3 haem domain complexed with the fatty acid
substrate, palmitoleic acid, Nat. Struct. Biol. 4 (1997)
140^146.
[148] J.T. Hazzard, S. Govindara, T.L. Poulos, G. Tollin, Elec-
tron transfer between the FMN and heme domains of cy-
tochrome P450BM3, J. Biol. Chem. 272 (1997) 7922^7926.
[149] J.A. Peterson, I. Sevrioukova, G. Truan, S.E. Graham-Lor-
ence, P450BM3: A tale of two domains ^ or is it three?,
Steroids 62 (1997) 117^123.
[150] I. Sevrioukova, G. Truan, J.A. Peterson, The £avoprotein
domain of P450BM3: expression, puri¢cation and proper-
ties of the £avin adenine dinucleotide- and £avin mononu-
cleotide-binding subdomains, Biochemistry 35 (1996) 7528^
7535.
[151] A.W. Munro, J.G. Lindsay, J.R. Coggins, S.M. Kelly, N.C.
Price, Structural and enzymological analysis of the interac-
tion of isolated domains of cytochrome P450BM3, FEBS
Lett. 343 (1994) 70^74.
[152] S.N. Da¡, S.K. Chapman, K.L. Turner, R.A. Holt, S. Go-
vindaraj, T.L. Poulos, A.W. Munro, Redox control of the
catalytic cycle of £avocytochrome P450BM3, Biochemistry
36 (1997) 13816^13823.
[153] R. Bernhardt, A. Makower, G.-R. Ja«nig, K. Ruckpaul,
Selective chemical modi¢cation of a functionally linked ly-
sine in cytochrome P-450 LM2, Biochim. Biophys. Acta
785 (1984) 186^190.
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374372
[154] R. Bernhardt, K. Pommerening, K. Ruckpaul, Modi¢ca-
tion of carboxyl groups on NADPH-cytochrome P-450 re-
ductase involved in binding of cytochromes c and P-450
LM2, Biochem. Int. 14 (1987) 823^832.
[155] R. Bernhardt, R. Kraft, A. Otto, K. Ruckpaul, Electro-
static interactions between cytochrome P-450 LM2 and
NADPH-cytochrome P-450 reductase, Biomed. Biochim.
Acta 47 (1988) 581^592.
[156] W. Schwarze, R. Bernhardt, G.-R. Ja«nig, K. Ruckpaul,
Fluorescent energy transfer measurements on £uorescein
isothiocyanate modi¢ed cytochrome P-450 LM2, Biochem.
Biophys. Res. Commun. 113 (1983) 353^360.
[157] P. Hlavica, J. Kellermann, I. Golly, M. Lehnerer, Chemical
modi¢cation of Tyr34 and Tyr129 in rabbit liver microso-
mal cytochrome b5 a¡ects interaction with cytochrome
P450 2B4, Eur. J. Biochem. 224 (1994) 1039^1046.
[158] P. Hlavica, I. Golly, J. Wolf, In£uence of N1N-dimethylani-
line on the association of phenobarbital-induced cyto-
chrome P450 and NADPH-cytochrome c (P450) reductase
in a reconstituted rabbit liver microsomal system, Biochim.
Biophys. Acta 915 (1987) 28^36.
[159] P. Hlavica, Analysis of the mode of interaction of
NADPH-cytochrome P450 reductase and cytochrome b5
with cytochrome P450LM2 (P450IIB4), in: A.I. Archakov,
G.I. Bachmanova (Eds.), Cytochrome P450: Biochemistry
and Biophysics, INCO-TNC, Moscow, 1992, pp. 216^
221.
[160] I. Golly, P. Hlavica, Chemical modi¢cation of lysine resi-
dues in cytochrome P450 LM2 (P450IIB4): in£uence on
heme liganding of arylamines, Arch. Biochem. Biophys.
292 (1992) 287^294.
[161] I. Golly, P. Hlavica, Inactivation of phenobarbital-induc-
ible rabbit liver microsomal cytochrome P450 by allyliso-
propylacetamide: impact on electron transfer, Biochim.
Biophys. Acta 1142 (1993) 74^82.
[162] I. Golly, P. Hlavica, W. Schartau, The functional role of
cytochrome b5 reincorporated into hepatic microsomal
fractions, Arch. Biochem. Biophys. 260 (1988) 232^
240.
[163] M. Lehnerer, J. Schulze, S.J. Pernecky, D.F.V. Lewis, M.
Eulitz, P. Hlavica, In£uence of mutation of the amino-ter-
minal signal anchor sequence of cytochrome P450 2B4 on
enzyme structure and electron transfer processes, J. Bio-
chem. 124 (1998) 396^403.
[164] P. Hlavica, M. Kehl, Comparative studies on the N-oxida-
tion of aniline and N1N-dimethylaniline by rabbit liver mi-
crosomes, Xenobiotica 6 (1976) 679^689.
[165] M. Lehnerer, J. Schulze, A. Petzold, R. Bernhardt, P. Hlav-
ica, Rabbit liver cytochrome P450 2B5: high-level expres-
sion of the full-length protein in Escherichia coli, puri¢ca-
tion and catalytic activity, Biochim. Biophys. Acta 1245
(1995) 107^115.
[166] H.W. Strobel, A.V. Hodgson, S. Shen, NADPH cyto-
chrome P450 reductase and its structural and functional
domains, in: P.R. Ortiz de Montellano (Ed.), Cytochrome
P450, Plenum, New York, 1995, pp. 225^244.
[167] H.W. Strobel, S.G. Nadler, D.R. Nelson, Cytochrome P-
450: cytochrome P-450 reductase interactions, Drug Metab.
Rev. 20 (1989) 519^533.
[168] S.G. Nadler, H.W. Strobel, Identi¢cation and characteriza-
tion of an NADPH-cytochrome P450 reductase derived
peptide involved in binding to cytochrome P450, Arch. Bio-
chem. Biophys. 290 (1991) 277^284.
[169] A.L. Shen, C.B. Kasper, Role of acidic residues in the
interaction of NADPH-cytochrome P450 oxidoreductase
with cytochrome P450 and cytochrome c, J. Biol. Chem.
270 (1995) 27475^27480.
[170] Y. Nisimoto, Localization of cytochrome c-binding domain
on NADPH-cytochrome P450 reductase, J. Biol. Chem. 261
(1986) 14232^14237.
[171] Y.-T. Chang, P.B. Sti¡elman, I.A. Vasker, G.H. Loew, A.
Bridges, L. Waskell, Construction of a 3D model of cyto-
chrome P4502B4, Protein Eng. 10 (1997) 119^129.
[172] A. Bridges, L. Gruenke, Y.-T. Chang, I.A. Vasker, G.
Loew, L. Waskell, Identi¢cation of the binding site on cy-
tochrome P450 2B4 for cytochrome b5 and cytochrome
P450 reductase, J. Biol. Chem. 273 (1998) 17036^
17049.
[173] J.B. Schenkman, Protein^protein interactions, in: J.B.
Schenkman, H. Griem (Eds.), Cytochrome P450, Springer,
Berlin, 1993, pp. 527^545.
[174] I. Janssen, M. Curti, P.M. Epstein, J.A. Peterson, J.B.
Schenkman, Relationship between phosphorylation and cy-
tochrome P450 destruction, Arch. Biochem. Biophys. 283
(1990) 285^292.
[175] P.M. Epstein, M. Curti, I. Jansson, C.-H. Huang, J.B.
Schenkman, Phosphorylation of cytochrome P450: regula-
tion by cytochrome b5, Arch. Biochem. Biophys. 271 (1989)
424^432.
[176] A.I. Voznesensky, J.B. Schenkman, Quantitative analyses
of electrostatic interactions between NADPH-cytochrome
P450 reductase and cytochrome P450 enzymes, J. Biol.
Chem. 269 (1994) 15724^15731.
[177] P.P. Tamburini, R.W. White, J.B. Schenkman, Chemical
characterization of protein-protein interactions between cy-
tochrome P450 and cytochrome b5, J. Biol. Chem. 260
(1985) 4007^4015.
[178] P.P. Tamburini, J.B. Schenkman, Mechanism of interaction
between cytochromes P450RLM5 and b5 : evidence for an
electrostatic mechanism involving cytochrome b5 heme pro-
pionate groups, Arch. Biochem. Biophys. 245 (1986) 512^
522.
[179] P.P. Tamburini, J.B. Schenkman, Di¡erences in the mech-
anism of functional interaction between NADPH-cyto-
chrome P450 reductase and its redox partners, Mol. Phar-
macol. 30 (1986) 178^185.
[180] H.A. Dailey, P. Strittmatter, Modi¢cation and identi¢ca-
tion of cytochrome b5 carboxyl groups involves in pro-
tein-protein interaction with cytochrome b5 reductase,
J. Biol. Chem. 254 (1979) 5388^5396.
[181] R.O. Juvonen, M. Iwasaki, M. Negishi, Roles of residues
129 and 209 in the alteration by cytochrome b5 of hydrox-
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374 373
ylase activities in mouse 2A P450s, Biochemistry 31 (1992)
11519^11523.
[182] R. Bernhardt, I.C. Gunsalus, Reconstitution of cytochrome
P4502B4 (LM2) activity with camphor and linalool mono-
oxygenase electron donors, Biochem. Biophys. Res. Com-
mun. 187 (1992) 310^317.
[183] M.L. Klein, A.J. Fulco, Critical residues involved in FMN
binding and catalytic activity in cytochrome P450BMÿ3,
J. Biol. Chem. 268 (1993) 7553^7561.
[184] Y. Nisimoto, Y. Shibata, Studies on FAD- and FMN-bind-
ing domains in NADPH-cytochrome P-450 reductase from
rabbit liver microsomes, J. Biol. Chem. 257 (1982) 12532^
12539.
BBABIO 44955 23-11-00 Cyaan Magenta Geel Zwart
D.F.V. Lewis, P. Hlavica / Biochimica et Biophysica Acta 1460 (2000) 353^374374
